跳至主要内容
临床试验/CTRI/2024/02/063353
CTRI/2024/02/063353尚未招募3 期

To compare the efficacy and adverse effects of oral tofacitinib and oral methylprednisolone mini-pulse and combination of both in treatment of alopecia areata: A Randomized Controlled Trial. - NI

Institute of Medical Sciences BH0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Clinically diagnosed cases of alopecia areata with severity of alopecia tool (SALT) score of 10 % or over.
  • 2. Age: 18 to 65 years
  • 3. Patients not taking systemic drug in last 1 month and topical treatment in last 15 days.
  • - All participants who give consent for the study

排除标准

  • 1. Patients having history or active tuberculosis.
  • 2. Patients with Pregnancy and lactating mother.
  • 3. Patients with uncontrolled renal, hepatic,
  • hematological or heart disease.
  • 4. Patients with diabetes mellitus and hypertension.

研究者

发起方
Institute of Medical Sciences BH

相似试验